LGMD2I is a dystroglycanopathy, caused by homozygous or compound heterozygous mutation in the FKRP gene (fukutin-related protein) [82]. This evidence concerns the gene FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.